Founded in 2015, Orchard Therapeutics aspires to end the devastation caused by genetic and other severe diseases through the curative potential of HSC gene therapy. With its global and U.S. headquarters in London and Boston, respectively, the company offers a diverse and dynamic work environment and is always looking to expand its team with talented individuals who are passionate about making a difference for patients and their families.
The Virtual Speed Networking event will give attendees an opportunity to gain industry knowledge and network with several mentors from different functions across the organisation, as well as provide an opportunity to learn more about Orchard and the biopharmaceutical industry. Attendees will also be given the opportunity to establish and form meaningful professional relationships with the mentors for potential future career advice and coaching.
Chief Technical Officer
Nicoletta joined Orchard Therapeutics this summer. She is responsible for leading all aspects of technical operations, including process and analytical development, manufacturing, supply chain, engineering and CMC lifecycle management.
Director, Market Access
Christopher has been with Orchard Therapeutics since the end of 2019, and he brought with him more than 20 years of experience in Pharma and biotechnology.
Snr Director, Regulatory
Gustavo joined Orchard Therapeutics earlier this year. He is a pharmacist with postgraduate degrees in industrial pharmacy and management. He is an experienced regulatory affairs professional with over 20 years of experience in the pharmaceutical industry.
Snr Manager, Clinical Operations
Tina recently joined Orchard Therapeutics from Shionogi Europe. Alongside Study Management she also has Line Management and mentoring experience. She has enjoyed this aspect of her role as she found guiding and training junior members of the team very rewarding.
Director, Corporate QA
Jeff joined Orchard at the end of 2017, after a few years as a Senior Quality Specialist at Pearl Therapeutics. Jeff has over 15 years of experience in industry, beginning as an analytical development chemist and progressing into various Quality Assurance roles.
Manager, Pharmacovigilance, Training, Oversight, Compliance
Jennifer joined Orchard Therapeutics earlier this year. She previously worked at GSK for over 8 years where she was in PV operations which involved vendor management, on time reporting QC of SAE reports and working across multifunctional teams in the clinical space.
Chief HR Officer
John joined Orchard therapeutics in the spring of 2018. He oversees global human resources (HR) which includes talent acquisition and talent management, learning and organizational development, total rewards, and HR business partnering.
Program Mngmt & Leadership
Claire joined Orchard as a Senior Director, Program Leader at the beginning of 2020. She leads Program Strategy Teams to develop integrated cross functional development strategies for Orchard’s assets. Before Orchard, she spent 10 years at Amgen working on marketed and pre-registrational product development and business transformational initiatives.
Bayo joined Orchard earlier this year. He is a respected and dedicated result-oriented quality professional with more than ten years’ experience in
computer system validation, IT governance, processes and practices.
Cell & Gene Therapy Tech
Koval joined Orchard earlier this year. He did his undergraduate degree at the University of Westminster and a Masters of Research at Queen Mary University. He holds a PhD in Vascular Sciences where he focused on cell & molecular biology.
Manager, MasterControl System
Meena joined Orchard around a year ago. Her career spans 25 years across Academia, NHS and Pharma Industry/Biotech. She has extensive scientific expertise in mammalian cell-culture/bioreactors and good working knowledge of Quality Management Systems (Good Manufacturing Practice & Good Laboratory Practice).
Associate Study Manager
Alex has been with Orchard Therapeutics since Autumn 2019. Previously Alex had four years’ experience within clinical research. He has gained his professional experience working for a contract research organisation, that specialises in early phase clinical trials within infectious diseases. He has gained experience in various roles, mainly focusing on clinical operations.